Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. (26th December 2017)

• Record Type: Journal Article
• Authors: Taqueti, Viviany R; Solomon, Scott D; Shah, Amil M; Desai, Akshay S; Groarke, John D; Osborne, Michael T; Hainer, Jon; Bibbo, Courtney F; Dorbala, Sharmila; Blankstein, Ron; Di Carli, Marcelo F
• Is Part Of: European heart journal. Volume 39:Number 10(2018)
• Page Start: 840
• Page End: 849
• Publication Date: 2017-12-26
• Subjects: Coronary microvascular ischaemia -- Coronary flow reserve -- Diastolic dysfunction -- Cardiac troponin -- Heart failure with preserved ejection fraction; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; 616.12005
• DOI: 10.1093/eurheartj/ehx721
• Languages: English
• ISSNs: 0195-668X

Abstract

Abstract: Aims: Coronary microvascular ischaemia, cardiomyocyte injury and stiffness may play an important role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). To date, the relationship between coronary flow reserve (CFR), myocardial injury, diastolic dysfunction, and future HFpEF risk is unknown. Methods and results: Consecutive patients ( n = 201) undergoing evaluation for suspected coronary artery disease (CAD) with stress myocardial perfusion positron emission tomography, serum troponin, and transthoracic echocardiography who did not have flow-limiting CAD or reduced left ventricular ejection fraction were identified. Patients were followed up (median 4.1 years) for cardiovascular death and hospitalization for non-fatal myocardial infarction or heart failure. Coronary flow reserve was quantified as stress/rest myocardial blood flow. Early diastolic flow ( E ) and relaxation ( e ′) velocities were obtained via transmitral and tissue Doppler, respectively. Patients with impaired CFR (<2, n = 108) demonstrated linearly decreasing e ′ and increasing E / e ′ consistent with worsening diastolic function ( P for trend <0.0001). A detectable troponin was associated with diastolic dysfunction only in the presence of impaired CFR (interaction P = 0.002). In adjusted analyses, impaired CFR was independently associated with diastolic dysfunction ( E / e ′septal > 15, adjusted OR 2.58, 95%CI 1.22–5.48) and composite cardiovascular outcomes or HFpEF hospitalization alone (adjusted HR 2.47, 95%CI 1.09–5.62). Patients with both impaired CFR and diastolic dysfunction demonstrated >five-fold increased risk of HFpEF hospitalization ( P < 0.001). Conclusion: In symptomatic patients without overt CAD, impaired CFR was independently associated with diastolic dysfunction and adverse events, especially HFpEF hospitalization. The presence of both coronary microvascular and diastolic dysfunctions was associated with a markedly increased risk of HFpEF events.